Low-Level Environmental Phthalate Exposure Associates with Urine Metabolome Alteration in a Chinese Male Cohort.

The general population is exposed to phthalates through various sources and routes. Integration of omics data and epidemiological data is a key step toward directly linking phthalate biomonitoring data with biological response. Urine metabolomics is a powerful tool to identify exposure biomarkers and delineate the modes of action of environmental stressors. The objectives of this study are to investigate the association between low-level environmental phthalate exposure and urine metabolome alteration in male population, and to unveil the metabolic pathways involved in the mechanisms of phthalate toxicity. In this retrospective cross-sectional study, we studied the urine metabolomic profiles of 364 male subjects exposed to low-level environmental phthalates. Di(2-ethylhexyl) phthalate (DEHP) and dibutyl phthalate (DBP) are the most widely used phthalates. ∑DEHP and MBP (the major metabolite of DBP) were associated with significant alteration of global urine metabolome in the male population. We observed significant increase in the levels of acetylneuraminic acid, carnitine C8:1, carnitine C18:0, cystine, phenylglycine, phenylpyruvic acid and glutamylphenylalanine; and meanwhile, decrease in the levels of carnitine C16:2, diacetylspermine, alanine, taurine, tryptophan, ornithine, methylglutaconic acid, hydroxyl-PEG2 and keto-PGE2 in high exposure group. The observations indicated that low-level environmental phthalate exposure associated with increased oxidative stress and fatty acid oxidation and decreased prostaglandin metabolism. Urea cycle, tryptophan and phenylalanine metabolism disruption was also observed. The urine metabolome disruption effects associated with ∑DEHP and MBP were similar, but not identical. The multibiomarker models presented AUC values of 0.845 and 0.834 for ∑DEHP and MBP, respectively. The predictive accuracy rates of established models were 81% for ΣDEHP and 73% for MBP. Our results suggest that low-level environmental phthalate exposure associates with urine metabolome disruption in male population, providing new insight into the early molecular events of phthalate exposure.

[1]  L. Birnbaum,et al.  Arsenic and Environmental Health: State of the Science and Future Research Opportunities , 2015, Environmental health perspectives.

[2]  M. Mendez,et al.  Metabolomic characteristics of arsenic-associated diabetes in a prospective cohort in Chihuahua, Mexico. , 2015, Toxicological sciences : an official journal of the Society of Toxicology.

[3]  Heqing Shen,et al.  Urinary Metabolomics Revealed Arsenic Internal Dose-Related Metabolic Alterations: A Proof-of-Concept Study in a Chinese Male Cohort , 2014, Environmental science & technology.

[4]  F. Hu,et al.  Association of Urinary Concentrations of Bisphenol A and Phthalate Metabolites with Risk of Type 2 Diabetes: A Prospective Investigation in the Nurses’ Health Study (NHS) and NHSII Cohorts , 2014, Environmental health perspectives.

[5]  Xueping Chen,et al.  Toxicity and Estrogenic Endocrine Disrupting Activity of Phthalates and Their Mixtures , 2014, International journal of environmental research and public health.

[6]  J. Cravedi,et al.  Potential Input From Metabolomics for Exploring and Understanding the Links Between Environment and Health , 2014, Journal of toxicology and environmental health. Part B, Critical reviews.

[7]  T. Spector,et al.  Alcohol-induced metabolomic differences in humans , 2013, Translational Psychiatry.

[8]  S. London,et al.  Phthalate Exposure and Allergy in the U.S. Population: Results from NHANES 2005–2006 , 2013, Environmental health perspectives.

[9]  J. Cravedi,et al.  Metabolomics Tools for Describing Complex Pesticide Exposure in Pregnant Women in Brittany (France) , 2013, PloS one.

[10]  D. Lamb,et al.  The use of genomics, proteomics, and metabolomics in identifying biomarkers of male infertility. , 2013, Fertility and sterility.

[11]  Fabian J Theis,et al.  Effects of smoking and smoking cessation on human serum metabolite profile: results from the KORA cohort study , 2013, BMC Medicine.

[12]  G. Remuzzi,et al.  Translating the basic knowledge of mitochondrial functions to metabolic therapy: role of L-carnitine. , 2013, Translational research : the journal of laboratory and clinical medicine.

[13]  H. Ressom,et al.  Feasibility of Identifying the Tobacco-related Global Metabolome in Blood by UPLC–QTOF-MS , 2012, Journal of Proteome Research.

[14]  U. N. Joensen,et al.  Phthalate Excretion Pattern and Testicular Function: A Study of 881 Healthy Danish Men , 2012, Environmental health perspectives.

[15]  Heqing Shen,et al.  Phthalates exposure of Chinese reproductive age couples and its effect on male semen quality, a primary study. , 2012, Environment international.

[16]  Heqing Shen,et al.  The metabonomics of combined dietary exposure to phthalates and polychlorinated biphenyls in mice. , 2012, Journal of pharmaceutical and biomedical analysis.

[17]  James K. Ellis,et al.  Metabolic profiling detects early effects of environmental and lifestyle exposure to cadmium in a human population , 2012, BMC Medicine.

[18]  M. Tsai,et al.  Metabolomic characterization of laborers exposed to welding fumes. , 2012, Chemical research in toxicology.

[19]  R. Snyder,et al.  Metabolomics of brain and reproductive organs: characterizing the impact of gestational exposure to butylbenzyl phthalate on dams and resultant offspring , 2012, Metabolomics.

[20]  P. Beaune,et al.  Combined Transcriptomic–1H NMR Metabonomic Study Reveals That Monoethylhexyl Phthalate Stimulates Adipogenesis and Glyceroneogenesis in Human Adipocytes , 2011, Journal of proteome research.

[21]  Qian Wu,et al.  Phthalate metabolites in urine from China, and implications for human exposures. , 2011, Environment international.

[22]  Yu Cao,et al.  Metabolomic evaluation of di-n-butyl phthalate-induced teratogenesis in mice , 2011, Metabolomics.

[23]  S. Brunak,et al.  Many Putative Endocrine Disruptors Inhibit Prostaglandin Synthesis , 2010, Environmental health perspectives.

[24]  H. Kamp,et al.  The individual and combined metabolite profiles (metabolomics) of dibutylphthalate and di(2-ethylhexyl)phthalate following a 28-day dietary exposure in rats. , 2010, Toxicology letters.

[25]  Kyungho Choi,et al.  Influence of a five-day vegetarian diet on urinary levels of antibiotics and phthalate metabolites: a pilot study with "Temple Stay" participants. , 2010, Environmental research.

[26]  R. Tyl,et al.  Metabolomics in the assessment of chemical‐induced reproductive and developmental outcomes using non‐invasive biological fluids: application to the study of butylbenzyl phthalate , 2009, Journal of applied toxicology : JAT.

[27]  A. Calafat,et al.  Urinary Phthalate Metabolites in Relation to Preterm Birth in Mexico City , 2009, Environmental health perspectives.

[28]  Cécile Canlet,et al.  Identification of potential mechanisms of toxicity after di-(2-ethylhexyl)-phthalate (DEHP) adult exposure in the liver using a systems biology approach. , 2009, Toxicology and applied pharmacology.

[29]  Mark R. Viant,et al.  Environmental metabolomics: a critical review and future perspectives , 2009, Metabolomics.

[30]  S. Agrawal,et al.  Maternal di-(2-ethylhexyl)-phthalate exposure influences essential fatty acid homeostasis in rat placenta. , 2008, Placenta.

[31]  G. Latini,et al.  Phthalate exposure and male infertility. , 2006, Toxicology.

[32]  Ken Takahashi,et al.  Decreased Serum Free Testosterone in Workers Exposed to High Levels of Di-n-butyl Phthalate (DBP) and Di-2-ethylhexyl Phthalate (DEHP): A Cross-Sectional Study in China , 2006, Environmental health perspectives.

[33]  P. Vasseur,et al.  Dysregulation of ornithine decarboxylase activity, apoptosis and Bcl-2 oncoprotein in Syrian hamster embryo cells stage-exposed to di(2-ethylhexyl)phthalate and tetradecanoylphorbol acetate. , 1997, Carcinogenesis.

[34]  T. Hashimoto,et al.  The effect of di(ethylhexyl)phthalate on fatty acid oxidation and carnitine palmitoyltransferase in various rat tissues. , 1990, Biochimica et biophysica acta.

[35]  M. Rao,et al.  Di-(2-ethylhexyl)phthalate: an industrial plasticizer induces hypolipidemia and enhances hepatic catalase and carnitine acetyltransferase activities in rat and mice. , 1976, Life sciences.

[36]  Holger M Koch,et al.  A simple pharmacokinetic model to characterize exposure of Americans to Di-2-ethylhexyl phthalate , 2010, Journal of Exposure Science and Environmental Epidemiology.

[37]  R. Sasaki,et al.  The effects of phthalate esters on the tryptophan-niacin metabolism. , 2003, Advances in experimental medicine and biology.